한글목차

담관암 시장은 2023-2028년간 1억 3,740만 달러 확대되고, 예측 기간 동안 8.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 이 보고서는 담관암 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 신흥국 시장에서의 화학요법 약물의 인기, 담관암 발병률 증가, 신약 승인 등이 시장을 주도하고 있습니다.

이 보고서는 향후 몇 년동안 담관암 시장의 성장을 가속하는 주요 요인 중 하나로 탄탄한 R&D 활동으로 인한 파이프라인 제품의 충당을 꼽고 있습니다. 또한, 다양한 전략과 차세대 염기서열 분석(NGS) 기반 검사의 채택은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 담관암 시장(2018-2022년)
• 유형별 분석(2018-2022년)
• 지역별 분석(2018-2022년)
• 국가별 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 간외 담관암 : 시장 규모와 예측(2023-2028년)
• 간내 담관암 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제7장 고객 상황

• 고객 상황 개요

제8장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제9장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제10장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제11장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• AstraZeneca Plc
• BridgeBio Pharma Inc
• Bristol Myers Squibb Co.
• Hutchison China Meditech Ltd.
• Incyte Corp.
• J-Pharma Co. Ltd.
• Les Laboratoires Servier
• Merck KGaA
• RemeGen Ltd.
• Sino Biopharmaceutical Ltd.

제12장 부록

영문목차

Bile Duct Cancer Market 2024-2028

The bile duct cancer market is forecasted to grow by USD 137.4 mn during 2023-2028, accelerating at a CAGR of 8.7% during the forecast period. The report on the bile duct cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing preference for chemotherapy drugs in developing countries, increasing incident of bile duct cancer, and new drug approvals.

Technavio's bile duct cancer market is segmented as below:

By Type

• Extrahepatic bile duct cancer
• Intrahepatic bile duct cancer

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the robust research and development activities fueling the pipeline as one of the prime reasons driving the bile duct cancer market growth during the next few years. Also, adoption of various strategies and next-generation sequencing (NGS) based testing will lead to sizable demand in the market.

The report on the bile duct cancer market covers the following areas:

• Bile Duct Cancer Market sizing
• Bile Duct Cancer Market forecast
• Bile Duct Cancer Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bile duct cancer market vendors that include 3D Biomedicine Science and Technology Co. Ltd., AstraZeneca Plc, BridgeBio Pharma Inc, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hutchison China Meditech Ltd., Incyte Corp., Intas Pharmaceuticals Ltd., J-Pharma Co. Ltd., Les Laboratoires Servier, Merck KGaA, NuCana plc, Pfizer Inc., RemeGen Ltd., Sanofi SA, Shanghai Miracogen Inc., Sino Biopharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., and Zhongshan Hospital. Also, the bile duct cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Bile Duct Cancer Market 2018 - 2022
  • Historic Market Size - Data Table on Global Bile Duct Cancer Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Extrahepatic bile duct cancer - Market size and forecast 2023-2028
  • Chart on Extrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Data Table on Extrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Chart on Extrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
  • Data Table on Extrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• 6.4 Intrahepatic bile duct cancer - Market size and forecast 2023-2028
  • Chart on Intrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Data Table on Intrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Chart on Intrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
  • Data Table on Intrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 11.4 BridgeBio Pharma Inc
  • BridgeBio Pharma Inc - Overview
  • BridgeBio Pharma Inc - Product / Service
  • BridgeBio Pharma Inc - Key offerings
• 11.5 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 11.6 Hutchison China Meditech Ltd.
  • Hutchison China Meditech Ltd. - Overview
  • Hutchison China Meditech Ltd. - Business segments
  • Hutchison China Meditech Ltd. - Key offerings
  • Hutchison China Meditech Ltd. - Segment focus
• 11.7 Incyte Corp.
  • Incyte Corp. - Overview
  • Incyte Corp. - Product / Service
  • Incyte Corp. - Key offerings
• 11.8 J-Pharma Co. Ltd.
  • J-Pharma Co. Ltd. - Overview
  • J-Pharma Co. Ltd. - Product / Service
  • J-Pharma Co. Ltd. - Key offerings
• 11.9 Les Laboratoires Servier
  • Les Laboratoires Servier - Overview
  • Les Laboratoires Servier - Business segments
  • Les Laboratoires Servier - Key offerings
  • Les Laboratoires Servier - Segment focus
• 11.10 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
• 11.11 RemeGen Ltd.
  • RemeGen Ltd. - Overview
  • RemeGen Ltd. - Product / Service
  • RemeGen Ltd. - Key offerings
• 11.12 Sino Biopharmaceutical Ltd.
  • Sino Biopharmaceutical Ltd. - Overview
  • Sino Biopharmaceutical Ltd. - Business segments
  • Sino Biopharmaceutical Ltd. - Key offerings
  • Sino Biopharmaceutical Ltd. - Segment focus

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations